ÂÜÀòÂÒÂ×

Andrew Ha currently serves as BD Director and Business Development Lead at Deargen since February 2022. Prior to this role, Andrew held the position of Scientist at Janux Therapeutics from January 2021 to August 2021. Andrew completed a PhD in Biology at Stanford University from August 2016 to September 2020. Earlier experience includes serving as a Research Associate and Masters Student at The University of Toledo from June 2013 to June 2016, and as a Research Associate at Harvard Medical School from January 2010 to January 2013.